Results
Kawasaki disease
KAWASAKI DISEASE, DISEASES
During the study period, a total of 5155 KD patients who received IVIG therapy were identified. Among them, 1768 children were excluded by age criteria and another 19 patients were not enrolled due to combined use of TBSF and Privigen. Finally, 3368 KD children below the age of 2 years were enrolled (Fig. Flowchart of the patient and control selections. 5155 Kawasaki disease patients who were hospitalized under 2 years of age between January 1, 2015 to November 30, 2020 were recognized. Abbreviations: ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; IVIG, Intravenous immunoglobulin; ATC code, The Anatomical Therapeutic Chemical code.Demographic data of Kawasaki disease (KD) patients receiving two different brands of immunoglobulin. Expressed as n (%).